Teligent, Inc. to Hold Conference Call for Third Quarter 2017 Results
October 26, 2017 10:00 ET
|
Teligent, Inc.
BUENA, N.J., Oct. 26, 2017 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, announced the Company will hold a conference call at 4:30pm...
Teligent, Inc. Announces FDA Approval of Partnered ANDA for Desonide Lotion, 0.05%
October 02, 2017 13:37 ET
|
Teligent, Inc.
BUENA, N.J., Oct. 02, 2017 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s...
Teligent, Inc. Announces FDA Approval of Triamcinolone Acetonide Cream USP, 0.1%
September 19, 2017 08:00 ET
|
Teligent, Inc.
BUENA, N.J., Sept. 19, 2017 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s...
Teligent, Inc. Appoints Thomas J. Sabatino, Jr. to Board of Directors
September 18, 2017 16:45 ET
|
Teligent, Inc.
BUENA, N.J., Sept. 18, 2017 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has appointed Thomas J. Sabatino, Jr. to...
Teligent, Inc. to Present at Morgan Stanley 15th Annual Global Healthcare Conference on September 12, 2017
September 12, 2017 08:00 ET
|
Teligent, Inc.
BUENA, N.J., Sept. 12, 2017 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at the Morgan Stanley 15th Annual Global...
Teligent, Inc. Announces FDA Approval of Clobetasol Propionate Cream USP, 0.05%, Emollient
August 22, 2017 09:46 ET
|
Teligent, Inc.
BUENA, N.J., Aug. 22, 2017 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s...
Teligent, Inc. Announces Second Quarter 2017 Results
August 08, 2017 16:01 ET
|
Teligent, Inc.
BUENA, N.J., Aug. 08, 2017 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the second quarter...
Teligent, Inc. to Hold Conference Call for Second Quarter 2017 Results
July 28, 2017 08:00 ET
|
Teligent, Inc.
BUENA, N.J., July 28, 2017 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, announced the Company will hold a conference call at 4:30pm...